Antibody Discovery Market Growth

Global Antibody Discovery Market Growth is Anticipated at CAGR of 10.5%; Market Value to Grow to USD 6.6 billion by 2035 | Roots Analysis

According to a recently published report by Roots Analysis, antibody-based therapeutics have emerged as one of the fastest growing segments in the biopharmaceutical industry, owing to their high specificity, robust clinical efficacy, and expanding therapeutic applications. This growth has heightened the demand for antibody discovery services to accelerate novel candidate development, leading to significant overall antibody discovery market growth.

Global Antibody Discovery Market Overview

The global antibody discovery market is expected to reach around USD 6.6 billion by 2035, growing at a CAGR of 10.5% during the forecast period till 2035.

Given the ability of antibodies to target specific proteins, they are considered critical biomolecules for the treatment of various diseases, including cancer and autoimmune disorders. In fact, apart from cancer, antibody-based therapies have also demonstrated potential in the treatment of a variety of other diseases, including chronic clinical conditions and multiple rare disease indications. Over time, advancements in antibody research and discovery techniques has facilitated the development of different types of antibodies, such as monoclonal antibodies, bispecific antibodies, ADCs, antibody fragments and others. Such products have been designed to offer therapeutic effects by interacting with proteins / other biological targets distinctively, thereby presenting innovative and viable treatment options. In this context, the field of antibody discovery holds immense potential for future breakthroughs and is anticipated to evolve in the coming years. This evolution is expected to benefit a variety of stakeholders who have steadily promoted innovation in this domain.

Browse 185+ figures and 250+ market data tables spread across 605+ pages and detailed Table of Content on “Antibody Discovery Market, till 2035 by Antibody Discovery Step (Hit Generation, Lead Selection and Lead Optimization), Antibody Discovery Method (Hybridoma-based Methods, Phage Display Library-based Methods, Transgenic Animal-based Methods, Yeast Display-based Methods, Single Cell-based Methods and Other Methods), Nature of Antibody (Human Antibodies, Humanized Antibodies, Chimeric Antibodies and Murine Antibodies), Therapeutic Area (Oncological Disorders, Immunological Disorders, Infectious Diseases, Cardiovascular Disorders, Neurological Disorders and Other Disorders), Type of Antibody (Monoclonal Antibodies, Bispecific Antibodies, Antibody Drug Conjugates, Immunoconjugates and Other Antibodies), Type of End-User (In-house Players and Contract Research Organizations), and Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America)” here: https://www.rootsanalysis.com/reports/antibody-discovery-services-and-platforms-market/213.html

Market Drivers

Recent advancements in biotechnology, increasing demand for targeted therapies, rising prevalence of chronic diseases, increase in R&D expenditure in pharma and growing trend for outsourcing antibody discovery operations are some of the key factors that are driving the antibody discovery market growth. Moreover, the increase in investments from pharmaceutical companies, research organizations and biotechnology firms is further contributing to the market growth. Notably, regulatory acceptance and proven efficacy of antibody therapeutics has further accelerated their adoption. In order to accelerate the development of such therapies, pharmaceutical companies are increasingly outsourcing antibody discovery to CROs for leveraging cost savings, expertise, and operational efficiency. Collectively, these factors are fueling innovation, improving patient outcomes, and propelling significant growth in the antibody discovery services market.

Market Restraints

While the global antibody discovery market is experiencing substantial growth, there are certain restraints that can hinder growth of the industry. One of the primary challenges is regulatory compliance. As the stringent guidelines for preclinical testing, clinical trial design, manufacturing practices, and post-market surveillance require significant time and resources, delaying the time-to-market for antibody-based therapies. Further, the discovery and development of antibodies require specialized equipment, advanced technologies, and highly skilled personnel, leading to substantial financial investments, presenting significant challenges in antibody discovery. These factors collectively act as barriers to wider adoption, challenging the market’s ability to sustain its growth trajectory.

Growth Factors

Despite the aforementioned restraints, several growth factors continue to drive the global antibody discovery market forward. One notable factor is the increasing partnership and funding activity, indicating rising interest of established players in this domain. Moreover, technological advancements, including AI and ML have revolutionized the discovery of antibodies, offering the potential to accelerate the process, reduce costs, and improve the success rate of developing high-affinity, effective antibodies. Owing to the aforementioned factors, it can be anticipated that the global antibody discovery market will flourish remarkably in the foreseen future.

Global Antibody Discovery Market Segments

Antibody Discovery Services Market

Based on the antibody discovery step, the market is segmented into lead optimization, lead selection and hit generation.

• The lead optimization sub-segment led the global antibody discovery services market, capturing the largest revenue share of 61% in the current year.
• The lead selection sub segment is anticipated to grow at a higher CAGR of 13.0%, during the forecast period.

Based on the type of antibody discovery method, the market is segmented into hybridoma-based methods, phage display library-based methods, transgenic animal-based methods, yeast display-based methods, single cell-based methods and other methods.

• In the current year, the hybridoma-based methods sub-segment led the global antibody discovery services market, capturing the largest revenue share of 35%. This can be attributed to the popularity of hybridoma-based methods for the discovery of antibodies owing to their efficiency and low complexity.
• Further, the transgenic animal-based methods sub segment is anticipated to show the highest growth rate of 12.9%, during the forecast period.

Based on the nature of antibody, the market is segmented into human antibodies, humanized antibodies, chimeric antibodies and murine antibodies.

• The human antibodies sub-segment led the global antibody discovery services market, capturing the largest revenue share of 56% in the current year and is anticipated to show the highest growth rate of 12.5% during the forecast period.
• This can be attributed to several benefits associated with human antibodies, including reduced immunogenicity and high serum half-life in human body. It is worth mentioning that, in 2024, over 15 fully human monoclonal antibodies have been approved across various geographies.

Based on the therapeutic area, the market is segmented into oncological disorders, immunological disorders, infectious diseases, cardiovascular disorders, neurological disorders and other disorders.

• Oncological disorders sub-segment led the global antibody discovery services market, capturing the largest revenue share of 48% in the current year.
• Cardiovascular disorders sub segment is anticipated to grow at a higher CAGR of 13.0%, during the forecast period.

Based on the type of antibody, monoclonal antibodies, bispecific antibodies and immunoconjugates.

• In the current year, the monoclonal antibodies sub-segment led the global antibody discovery services market, capturing the largest revenue share of 60%. This can be attributed to the fact that monoclonal antibodies offer high specificity, consistency, and reproducibility, thereby making them ideal for targeted therapies.
• Further, the immunoconjugates sub segment is anticipated to show the highest growth rate of 14.9%, during the forecast period.

Based on the regional insights, the market is segmented into North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America.

• North America is dominating the global antibody discovery services market, accounting for the largest revenue share of 50% in the current year.
• The global antibody discovery services market in Asia-Pacific is anticipated to demonstrate lucrative growth during the forecast period.

Antibody Discovery Technology / Platforms Market

Based on the type of antibody, the market is segmented into monoclonal antibodies, bispecific antibodies, antibody drug conjugates and other antibodies.

• Monoclonal antibodies sub-segment led the global antibody discovery technology / platforms market, capturing the largest revenue share of 51% in the current year.
• The bispecific antibodies sub segment is anticipated to grow at a higher CAGR of 9.5%, during the forecast period.

Based on the end-user, the market is segmented into in-house players and contract research organizations.

• The in-house players sub-segment led the global antibody discovery technology / platforms market, capturing the largest revenue share of 98% in the current year.
• Further, the contract research organization sub-segment is expected to show the highest growth rate of 10.8%, during the forecast period.

Based on the regional insights, the market is segmented into North America, Europe and Asia-Pacific.

• North America is expected to dominate the global antibody discovery technology / platforms market, accounting for the largest revenue share of 60% in the current year.
• In Asia-Pacific, the global antibody discovery technology / platforms market is anticipated to demonstrate lucrative growth during the forecast period.

Key Companies Profiled

The global antibody discovery market report also includes detailed profiles of key players (listed below):

• Ablexis
• Abwiz Bio
• Abzena
• Aragen Life Sciences
• BIOTEM
• ChemPartner
• Creative Biolabs
• DetaiBio
• FairJourney Biologics
• Fusion Antibodies
• Genmab
• Harbour BioMed
• Immunome
• ImmunoPrecise Antibodies
• Integral Molecular
• Isogenica
• ProteoGenix
• Syd Labs
• Viva Biotech
• WuXi Biologics

You Can Download Free Sample PDF Copy of This Report At: https://www.rootsanalysis.com/reports/antibody-discovery-services-and-platforms-market/request-sample.html

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 1,500 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary

Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com